Cited by 29Nanoplatforms for cancer theranosticsMolecular Sensors and Ion DetectionLuminescence and Fluorescent Materials

Rational Design of NIR‐II Fluorescence/Photoacoustic Nanosensor Tailored for Mechanisms of Diabetes‐Related Breast Cancer

Open access
Zhang, Rui‐Rui, Ran, Xiao‐Yun, Yu, Kang‐Kang, Zhao, Yu, Zhang, Li‐Na, Lv, Xiao‐Fang, Zhang, Hong, Yu, Xiao‐Qi +1 more·2025·Advanced Materials

Abstract

Breast cancer (BC) is the second most common cause of cancer induced death worldwide. Current statistics has disclosed that the diabetic BC patients have significantly worse survival rate compared with nondiabetic BC patients. However, the specific mechanism is still being explored. Herein, a novel NIR‐II nanosensor DNPS for nitric oxide (NO) with fluorescence/photoacoustic (FL/PA) imaging capability is developed to explore the mechanism by which diabetes promoting breast cancer progression. In diabetic BC model, DNPS exhibits great advantages of low intrinsic background, high sensitivity, and deep tissue penetration and successfully confirmed the expression level of NO is higher than BC model, indicating that diabetes causes elevated nitric oxide levels in the tumor microenvironment. RNA‐seq analysis results show that hyperglycemia caused by diabetes leads to weakened immune response and initiates the transcription and translation of the inducible nitric oxide synthase (iNOS) gene to produce NO. Besides, the increased expression of carcinogens related to Nitric oxide synthase 2 (Nos2), such as Spp1, Mmp11, and Kitl, causes breast cancer to develop more rapidly. Here, NIR‐II imaging probe is applied first to study diabetes‐related breast cancer and certain reference value is provided for subsequent research on the mechanism of diabetes promoting the progression of breast cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/adma.202415891

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The DNO design combined advantages of fluorescence and PA imaging, including low background, high sensitivity, and deep tissue penetration, surpassing single-modal approaches.

    “This design combined the advantages of fluorescence and PA imaging, including low background, high sensitivity, and deep tissue penetration, thereby surpassing single-modal approaches.”
  • In the diabetes-related breast cancer model, DNO NPs enabled detection of intratumoral NO expression levels.

    “In the diabetes-related breast cancer model, DNO NPs successfully enabled the detection of intratumoral NO expression levels”
  • Li et al. developed a nitric oxide-activatable NIR-II fluorescent/PA dual-modal sensor DNO.

    “Li et al. developed a nitric oxide (NO)-activatable NIR-II fluorescent/PA dual-modal sensor, DNO (Fig. 15b)108.”
  • Hyperglycemia induced by diabetes directly elevated NO concentrations within the tumor microenvironment.

    “confirming that hyperglycemia induced by diabetes directly elevated NO concentrations within the tumor microenvironment (TME).”
  • DNO operated via an intramolecular photoinduced electron transfer (PET) mechanism, enabling an off/on fluorescence switch.

    “It operated via an intramolecular photoinduced electron transfer (PET) mechanism, enabling an “off/on” fluorescence switch.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 38 references couldn’t be matched to a known paper.

Research works printed but not linked: 31

  1. D. Yach, D. Stuckler, K. D. Brownell, Nat. Med. 2006, 12, 62.
  2. M. Brownlee, Nature 2001, 414, 813.
  3. D. L. Monticciolo, S. F. Malak, S. M. Friedewald, P. R. Eby, M. S. Newell, L. Moy, S. Destounis, J. W. T. Leung, R. E. Hendrick, D. Smetherman, J. Am. Coll. Radiol. 2021, 18, 1280.
  4. P. Chou, H. H. Choi, Y. Huang, E. Fuentes-Mattei, G. Velazquez- Torres, F. Zhang, L. Phan, J. Lee, Y. Shi, J. A. Bankson, Y. Wu, H. Wang, R. Zhao, S. J. Yeung, M. Lee, Cancer Commun. 2021, 41, 414.
  5. C. C. Capellen, J. Ortega-Rodas, M. J. Morwitzer, H. M. N. Tofilau, M. Dunworth, R. A. Casero, S. Chandra, Breast Cancer Res. Treat. 2021, 190, 255.
  6. V. V. Holotiuk, A. Y. Kryzhanivsk, I. K. Churpiy, B. B. Tataryn, D. Y. Ivasiutyn, Exp. Oncol. 2023, 41, 210.
  7. M. C. Jen, M. C. Serrano, R. Van Lith, G. A. Ameer, Adv. Funct. Mater. 2012, 22, 239.
  8. S. M. Andrabi, N. S. Sharma, A. Karan, S. M. S. Shahriar, B. Cordon, B. Ma, J. Xie, Adv. Sci. 2023, 10, 2303259.
  9. A. Ramesh, S. Kumar, A. Brouillard, D. Nandi, A. Kulkarni, Adv. Mater. 2020, 32, 2000648.
  10. Z. Chen, H. Zhang, Y. Lyu, K. Lv, H. Xing, P. Shen, Z. Guo, G. Li, D. Ma, Adv. Funct. Mater. 2024, 34, 2402591.
  11. X.-X. Chen, L.-Y. Niu, Q.-Z. Yang, Anal. Chem. 2021, 93, 3922.
  12. F. H. Khan, E. Dervan, D. D. Bhattacharyya, J. D. McAuliffe, K. M. Miranda, S. A. Glynn, Int. J. Mol. Sci. 2020, 21, 9393.
  13. F. Vannini, K. Kashfi, N. Nath, Redox Biol. 2015, 6, 334.
  14. Z. Xu, Q. Luo, Y. He, Y. He, X. Zhang, J. Wang, S. Ni, D. Gao, D. Wang, Adv. Funct. Mater. 2024, 34, 2314536.
  15. H. He, T. He, Z. Zhang, X. Xu, H. Yang, X. Qian, Y. Yang, Chin. Chem. Lett. 2018, 29, 1497.
  16. H. Cai, X. Wu, L. Jiang, F. Yu, Y. Yang, Y. Li, X. Zhang, J. Liu, Z. Li, H. Bi, Chin. Chem. Lett. 2024, 35, 108946.
  17. L. Sun, X. Wang, R. Chen, X. Dong, J. Sun, C. Dong, H. Xie, X. Gu, C. Zhao, J. Mater. Chem. B 2024, 12, 2304.
  18. Y. Sun, P. Sun, Z. Li, L. Qu, W. Guo, Chem. Soc. Rev. 2022, 51, 7170.
  19. J. Tan, K. Yin, Z. Ouyang, R. Wang, H. Pan, Z. Wang, C. Zhao, W. Guo, X. Gu, Anal. Chem. 2021, 93, 16158.
  20. Y. Li, H. Zhu, X. Wang, Y. Cui, L. Gu, X. Hou, M. Guan, J. Wu, Y. Xiao, X. Xiong, X. Meng, X. Hong, CCS Chem. 2022, 4, 3735.
  21. Q. Lan, P. Yu, K. Yan, X. Li, F. Zhang, Z. Lei, J. Am. Chem. Soc. 2022, 144, 21010.
  22. J. Jo, J. Folz, M. E. Gonzalez, A. Paolì, A. Eido, E. Salfi, S. Tekula, S. Andò, R. Caruso, C. G. Kleer, X. Wang, R. Kopelman, ACS Nano 2023, 17, 4396.
  23. J. Li, R. Wang, Y. Sun, P. Xiao, S. Yang, X. Wang, Q. Fan, W. Wu, X. Jiang, ACS Appl. Mater. Interfaces 2021, 13, 54830.
  24. P. Xiao, Y. Sun, M. Liang, S. Yang, J. Li, L. Zhang, X. Jiang, W. Wu, Mater. Today Nano 2023, 24, 100404.
  25. C. Dong, Z. Zhang, H. Wu, X. Liang, S. Pang, K. Wu, J. Sun, X. Dong, L. Sun, X. Gu, C. Zhao, Chem. Sci. 2024, 15, 10969.
  26. X. Ran, P. Chen, Y. Liu, L. Shi, X. Chen, Y. Liu, H. Zhang, L. Zhang, K. Li, X. Yu, Adv. Mater. 2023, 35, 2210179.
  27. Y. Liu, X. Ran, D. Zhou, H. Zhang, Y. Chen, J. Xu, S. Chen, Q. Kong, X. Yu, K. Li, Adv. Funct. Mater. 2023, 34, 2311365.
  28. A. K. Yadav, M. C. Lee, M. Y. Lucero, S. Su, C. J. Reinhardt, J. Chan, ACS Cent. Sci. 2022, 8, 461.
  29. Y. Zhuang, X. Li, P. Zhan, G. Pi, G. Wen, Oncol. Rep. 2021, 45, 16.
  30. Y. Zhang, S. Li, X. Cui, Y. Wang, Apoptosis 2023, 28, 1546.
  31. K. Yudoh, H. Matsui, H. Tsuji, Clin. Exp. Metastasis 1997, 15, 557.

Cited by

Sorted by citations

Authors
Zhang, R., Ran, X., Yu, K., Zhao, Y., Zhang, L., Lv, X., Zhang, H., Yu, X., & Li, K.
Affiliations
  • Key Laboratory of Green Chemistry and Technology Ministry of Education College of Chemistry Sichuan University Chengdu 610064 China
  • Sichuan University (CN)
  • West China Hospital of Sichuan University (CN)
  • Xihua University (CN)
Corresponding author
Li, Kun
Venue
Advanced Materials
Publisher
Wiley
Published
2025-01-05
Volume
37
Issue
8
Pages
e2415891-e2415891
ISSN
  • 0935-9648 (ISSN-L)
  • 1521-4095
OpenAlex
W4406112312
Cited by
28
References
38
Citations by year
2026: 16 · 2025: 12
FWCI
6.78
Type
journal article
Language
en
Open access
Locations
  • Advanced Materials (publishedVersion)
  • PubMed (publishedVersion)
Funders
Innovative Research Group Project of the National Natural Science Foundation of China (U21A20308, 22077088)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
  • Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
Keywords
NIR-II fluorescence imaging, photoacoustic imaging, nitric oxide detection, fluorescent nanosensor, tumor microenvironment, inducible nitric oxide synthase, hyperglycemia, antitumor immunity, NOS2, osteopontin, MMP11, Kitl
MeSH terms
Animals, Breast Neoplasms, Female, Fluorescence, Humans, Infrared Rays, Nitric Oxide, Cell Line, Tumor, Mice, Nitric Oxide Synthase Type II, Photoacoustic Techniques, Optical Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review